Journal News

Do sperm offer the uterus
a secret handshake?

Researchers discover endometrial receptor that can recognize surface molecule
Laurel Oldach
Jan. 22, 2020

Why does it take 200 million sperm to fertilize a single egg?

One reason: When sperm arrive in the uterus, they are bombarded by the immune system. Perhaps, molecular anthropologist Pascal Gagneux says, many are needed so some will survive. On the other hand, the female may benefit by culling so many sperm.

“I’m a lonely zoologist in a medical school,” Gagneux said. “My elevator spiel is that all of life is one big compromise. (For an egg), being too easy to fertilize is bad; being too difficult to fertilize is also bad.”

Gagneux’s lab at the University of California, San Diego, has discovered the makings of something that might be compared to a secret handshake between sperm and the cells lining the uterus in mice and, perhaps, humans. Uterine cells, they report in the Journal of Biological Chemistry, express a receptor that recognizes a glycan molecule on the surface of sperm cells. This interaction might adjust the female’s immune response and help sperm make it through the leukocytic reaction. 

JBC-news-sperm-leukocytic-resposne-(1).jpg
Tecle et al. JBC 2019
An artistic rendering (not to scale) shows how the “secret handshake” between sperm and endometrial cells takes place. The surface of sperm is coated in glycans, branched structures that are rich in sialic acid. These can be recognized by sialic acid binding receptors, called siglecs, found on the surface of endometrial cells.

The leukocytic reaction is not well understood. What we do know, Gagneux said, is that “after crossing the cervix, millions of sperm — a U.S. population worth of sperm — that arrive in the uterus are faced by a barrage of macrophages and neutrophils.” 

This attack by the innate immune system kills most of the sperm cells in semen, winnowing hundreds of millions down to just a few hundred that enter the fallopian tubes. The defensive response may help prevent polyspermy, when an egg is fertilized by more than one sperm and cannot develop.

Sperm are coated in sialic acid–rich glycans, and the innate immune system uses sialic acid to differentiate human cells from invaders, so Gagneux and his lab expected that the glycan might interact with innate immune cells called neutrophils. But human neutrophils they tested were activated to a similar degree by sperm with and without sialic acid.

Meanwhile, the team noticed sialic acid–binding receptors called siglecs on endometrial cells. In solution, these endometrial receptors can bind to whole sperm. According to Gagneux, the binding interaction might help the sperm run the gantlet of the leukocytic response — for example, by dampening the immune response. Alternatively, it may be a way for uterine cells to weed out faulty sperm. In the immune system, siglecs help cells to recognize sialic acid molecules as markers of the body’s own cells, and in that context they can turn inflammation either up or down.

“It’s somewhat embarrassing how little we can say about what this (interaction) means,” Gagneux said. To understand its physiological significance, researchers first must look for direct interaction between sperm and intact uterine tissue — this paper looked at only sperm interacting with purified proteins and isolated cells. 

It’s humbling to work in such a poorly understood area, Gagneux said. Reproduction “is a very, very delicate tug-of-war at many levels. The fact that there is (also) this immune game going on is completely fascinating.”

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Laurel Oldach

Laurel Oldach is a former science writer for the ASBMB.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Light-activated small molecule could transform eye infection treatment
News

Light-activated small molecule could transform eye infection treatment

April 21, 2026

Contact lenses raise the risk of infectious keratitis, a leading cause of blindness worldwide. A biotech company is commercializing a light-activated therapy using a ROS-generating molecule to rapidly kill microbes in the cornea to preserve vision.

The molecular orchestra of memory
Feature

The molecular orchestra of memory

April 16, 2026

Calcium, calmodulin and calcium/calmodulin-dependent kinase II form a molecular axis that turns fleeting neural activity into lasting memories. New research shows how memories are stabilized, and possibly even protected or repaired.

Differences in pili structure modulate bacterial behavior
Journal News

Differences in pili structure modulate bacterial behavior

April 14, 2026

Researchers demonstrate how small changes in the structure of hair-like protein appendages can affect the behavior of Acinetobacter bacteria.

Cholesterol regulatory genes predict liver transplant outcomes
Journal News

Cholesterol regulatory genes predict liver transplant outcomes

April 10, 2026

Researchers identify a link between cholesterol-regulating genes and liver transplant success, which could improve donor screening and patient outcomes.

Lipid signatures for a rare neurological disorder
Journal News

Lipid signatures for a rare neurological disorder

April 10, 2026

Researchers find distinct lipid patterns linked to a rare autoimmune neurological disorder, offering hope for effective targeted therapies for patients.

Disease-linked mutations disrupt protein phase behavior
Journal News

Disease-linked mutations disrupt protein phase behavior

April 9, 2026

Researchers find that pathogenic missense mutations are enriched threefold in phrase-separating intrinsically disordered regions of proteins.